Related references
Note: Only part of the references are listed.Upper gastrointestinal safety of oral bisphosphonate in hospitalized patients
P. V. -Q. Nguyen et al.
OSTEOPOROSIS INTERNATIONAL (2021)
Trends in anticoagulant prescribing: a review of local policies in English primary care
Katherine H. Ho et al.
BMC HEALTH SERVICES RESEARCH (2020)
Safety and Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study
Chun-Li Wang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Increasing use of anticoagulants in Germany and its impact on hospitalization for gastrointestinal bleeding
Jan-Erik Guelker et al.
THROMBOSIS RESEARCH (2019)
Clinical and endoscopic features of severe acute gastrointestinal bleeding in elderly patients treated with direct oral anticoagulants: a multicentre study
David Deutsch et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Difference between the Upper and the Lower Gastrointestinal Bleeding in Patients Taking Nonvitamin K Oral Anticoagulants
Kyohei Maruyama et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials
Benjamin Scally et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study
Neena S. Abraham et al.
GASTROENTEROLOGY (2017)
Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs
Sven Pannach et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
Ka-Shing Cheung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study
Anna But et al.
DIABETOLOGIA (2017)
The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies
Ying He et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Stroke prevention in atrial fibrillation
Ben Freedman et al.
LANCET (2016)
Burden of high fracture probability worldwide: secular increases 2010-2040
A. Oden et al.
OSTEOPOROSIS INTERNATIONAL (2015)
The Danish Civil Registration System as a tool in epidemiology
Morten Schmidt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)
Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal bleeding risk
Vera E. Valkhoff et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study
Y. -L. Peng et al.
OSTEOPOROSIS INTERNATIONAL (2014)
New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis
I. Lisanne Holster et al.
GASTROENTEROLOGY (2013)
Diabetes is an independent risk factor for peptic ulcer bleeding: A nationwide population-based cohort study
Yen-Ling Peng et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
The association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort study
Jennifer A. Knopp-Sihota et al.
BMC GERIATRICS (2013)
Occult and obscure gastrointestinal bleeding: causes and clinical management
Don C. Rockey
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Upper gastrointestinal tract safety of risedronate: A pooled analysis of 9 clinical trials
H Taggart et al.
MAYO CLINIC PROCEEDINGS (2002)
Alendronate and naproxen are synergistic for development of gastric ulcers
DY Graham et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Share Paper
